Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System

Joseph J Maleszewski, Phillip M Young, Michael J Ackerman, Marc K Halushka, Joseph J Maleszewski, Phillip M Young, Michael J Ackerman, Marc K Halushka

No abstract available

Keywords: COVID-19; SARS-CoV-2; autopsy.

Figures

Figure.
Figure.
Studies needed to understand the long-term cardiovascular effects of COVID-19. A multidisciplinary approach is needed to gauge the frequency and severity of cardiovascular complications. CMR indicates cardiac magnetic resonance imaging; COVID-19, coronavirus disease 2019; CPET, cardiopulmonary exercise test; CRP, C-reactive protein; DTR, digital thermal reactivity studies; ESR, erythrocyte sedimentation rate; FMD, flow-mediated dilation; hsTnT, high-sensitivity troponin T; PCT, procalcitonin; and PT/PTT, prothrombin/partial thromboplastin time.

References

    1. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265–1273. doi: 10.1001/jamacardio.2020.3557
    1. Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, Daniels CJ. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6:116–118. doi: 10.1001/jamacardio.2020.4916
    1. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16:2. doi: 10.1186/1532-429X-16-2
    1. Androulakis E, Swoboda PP. The role of cardiovascular magnetic resonance in sports cardiology: current utility and future perspectives. Curr Treat Options Cardiovasc Med. 2018;20:86. doi: 10.1007/s11936-018-0679-y
    1. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618–625. doi: 10.1111/j.1365-2362.2009.02153.x

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir